|
新锐医药国际控股有限公司, 06108.HK - 财务比率 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
2014-12 |
2013-12 |
2012-12 |
变现能力分析 |
流动比率(倍) |
22.44 |
11.96 |
4.91 |
4.76 |
7.62 |
13.66 |
12.51 |
5.16 |
速动比率(倍) |
22.38 |
9.95 |
3.51 |
4.55 |
7.43 |
12.99 |
11.95 |
4.61 |
偿债能力分析 |
长期债项/股东权益(%) |
0.27 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
总债项/股东权益(%) |
0.33 |
0.0 |
0.0 |
3.56 |
0.0 |
0.0 |
0.0 |
8.93 |
总债项/资本运用(%) |
0.33 |
0.0 |
0.0 |
3.5 |
0.0 |
0.0 |
0.0 |
8.76 |
投资回报分析 |
股东权益回报率(%) |
0.0 |
4.58 |
0.0 |
0.0 |
3.1 |
9.79 |
8.16 |
11.4 |
资本运用回报率(%) |
0.0 |
4.52 |
0.0 |
0.0 |
3.06 |
9.63 |
8.04 |
11.19 |
总资产回报率(%) |
0.0 |
4.32 |
0.0 |
0.0 |
2.87 |
9.0 |
7.44 |
9.22 |
盈利能力分析 |
经营利润率(%) |
0.0 |
5.1 |
0.0 |
0.0 |
8.16 |
21.19 |
20.19 |
12.67 |
税前利润率(%) |
0.0 |
10.52 |
0.0 |
0.0 |
11.88 |
21.19 |
14.89 |
12.67 |
边际利润率(%) |
0.0 |
8.92 |
0.0 |
0.0 |
5.85 |
14.34 |
9.02 |
8.76 |
营运能力分析 |
存货周转率(倍) |
149.6 |
5.6 |
1.8 |
19.96 |
41.32 |
14.37 |
19.7 |
10.84 |
投资收益分析 |
派息比率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
90.25 |
0.0 |
相关统计 |
财政年度周最高价 |
0.0 |
0.0 |
0.89 |
1.05 |
5.0 |
2.16 |
2.16 |
0.0 |
财政年度周最低价 |
0.0 |
0.0 |
0.28 |
0.3 |
0.93 |
0.445 |
1.0 |
0.0 |
财政年度最高市盈率(倍) |
0.0 |
0.0 |
0.0 |
0.0 |
79.62 |
60.0 |
77.98 |
0.0 |
财政年度最低市盈率(倍) |
0.0 |
0.0 |
0.0 |
0.0 |
14.81 |
12.36 |
36.1 |
0.0 |
财政年度最高周息率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
2.5 |
0.0 |
财政年度最低周息率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
1.16 |
0.0 |
|
|